Lv1
45 积分 2021-03-30 加入
Novel drug targets in 2024
1天前
已完结
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
2个月前
已完结
Mylotarg: The Journey to FDA Reapproval and Broad International Approval
2个月前
已完结
Acute myeloid leukaemia
2个月前
已完结
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts
2个月前
已完结
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
4个月前
已关闭
Discovery of SHR5428 as a selective and noncovalent inhibitor of CDK7
4个月前
已完结
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction
5个月前
已完结
Pharmacological characterization of linzagolix, a novel, orally active, non-peptide antagonist of gonadotropin-releasing hormone receptors
6个月前
已完结
INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
7个月前
已完结
皖公网安备34019202002308
